Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 4, Number 5, August 2004

< previous issue | all issues | next issue >

Review article

Favourites:Add to Favourites

p53: Fighting Cancer
pp. 385-402(18)
Author: Selivanova, Galina

Favourites:Add to Favourites
Favourites:Add to Favourites

Harnessing Changes in Cellular Glycosylation in New Cancer Treatment Strategies
pp. 425-442(18)
Authors: Dwek, M. V.; Brooks, S. A.

Favourites:Add to Favourites

Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses
pp. 443-454(12)
Authors: Sarobe, P.; Huarte, E.; Lasarte, J. J.; Borras-Cuesta, F.

Favourites:Add to Favourites

Antiandrogens in Prostate Cancer Endocrine Therapy
pp. 455-461(7)
Authors: Culig, Z.; Bartsch, G.; Bartsch, A.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more